Recent Activity

Loading...

BIB

ProShares Ultra Nasdaq Biotechnology · NAS

  • Category Equity
  • Expense Ratio 0.95%
  • Listing Date Apr 08, 2010
  • Volume 15,321.0
  • Market Cap (AUM) $88.51M

Performance

+1.36%

1W

-0.67%

1M

-3.73%

3M

+31.13%

6M

-4.45%

YTD

-4.38%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • United States Treasury Bills 0.0% 08-AUG-2024N/A16.89%
  • U.S. DollarN/A12.62%
  • Amgen Inc.AMGN5.97%
  • Regeneron Pharmaceuticals, Inc.REGN5.70%
  • Vertex Pharmaceuticals IncorporatedVRTX5.59%
  • Gilead Sciences, Inc.GILD5.32%
  • Moderna, Inc.MRNA3.60%
  • Astrazeneca PLC Sponsored ADRAZN3.31%
  • Biogen Inc.BIIB2.33%
  • Illumina, Inc.ILMN1.48%

Technical Analysis of BIB 2024-05-10

Overview:

In analyzing the technical indicators for BIB stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potentia...

See more ...

Recent News & Updates